Management of chronic obstructive pulmonary disease by pharmacists in an internal medicine department

American Journal of Health-System Pharmacy

Volumn 66, Issue 10, 2009, Pages 890-893

  Mann, Rebecca P ^a   Zaiken, Kathy ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC PROCEDURE; ELECTRONIC MEDICAL RECORD; HUMAN; MEDICAL DOCUMENTATION; PHARMACIST; PRIORITY JOURNAL; REVIEW; SPIROMETRY; SYMPTOMATOLOGY;

EID: 65649084157     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080258     Document Type: Review

References (5)

1. Yankchick J. Implementation of a drug therapy monitoring clinic in a primary- care setting. Am J Health-Syst Pharm. 2000; 15(suppl 4):S30-4. (Pubitemid 32005745)
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. www.goldcopd.com/download.asp?intID=504 (accessed 2009 Feb 25).
3. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and management of patients with COPD. www.thoracic.org/sections/copd/ resources/copddoc.pdf (accessed 2009 Feb 25).
4. American Thoracic Society. Clinical assessment, testing and differential diagnosis. Testing. www.thoracic.org/sections/copd/for-health-professionals/ clinical-assessment-testing-and- differential-diagnosis/testing.html#1 (accessed 2009 Mar 19).
5. Dales R, Vandemheen K, Clinch J et al. Spirometry in the primary sare setting: influence on clinical diagnosis and management of airflow obstruction. Chest. 2005; 128:2443-2447 (Pubitemid 41507592)